Daniel P. Shine
Known title: DirectorCIK: 0001660681
Associated companies
Transaction History
| DCI | ▲ Buy | Grant | 900 | $0 | 1/2/2026 | View on chart |
| DCI | ▲ Buy | Grant | 100 | $0 | 12/8/2025 | View on chart |
| DCI | ▲ Buy | Grant | 900 | $0 | 1/2/2026 | View on chart |
| DCI | ▲ Buy | Grant | 100 | $0 | 12/8/2025 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Morgan Stanley Raises DCI Target to $95 After Earnings Beat
Donaldson reported an earnings beat and announced a new share buyback plan, which has drawn positive attention from analysts. Morgan Stanley maintained its Equal-Weight rating but raised its price target to $95, reflecting confidence in the company's durable cash flow. The stock is currently trading near its 52-week low, a level where some analysts suggest it may be undervalued.
Morgan Stanley Raises DCI Target to $95 After Earnings Beat. Donaldson reported an earnings beat and announced a new share buyback plan, which has drawn positive attention from analysts. Morgan Stanley maintained its Equal-Weight rating but raised its price target to $95, reflecting confidence in the company's durable cash flow. The stock is currently trading near its 52-week low, a level where some analysts suggest it may be undervalued.